Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;27(1):294-296.
doi: 10.3201/eid2701.203527.

Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda

Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda

Clara Bergmann et al. Emerg Infect Dis. 2021 Jan.

Abstract

Artemisinin resistance in Plasmodium falciparum is associated with nonsynonymous mutations in the Kelch 13 (K13) propeller domain. We found that 12.1% (8/66) of clinical P. falciparum isolates from Huye district, Rwanda, exhibited K13 mutations, including R561H, a validated resistance marker. K13 mutations appear to be increasing in this region.

Keywords: Kelch; Plasmodium falciparum; antimicrobial resistance; artemisinin; malaria; mutation; parasites; polymorphism; vector-borne infections.

PubMed Disclaimer

References

    1. Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al.; KARMA Consortium. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453–64. 10.1056/NEJMoa1513137 - DOI - PMC - PubMed
    1. Hanboonkunupakarn B, White NJ. The threat of antimalarial drug resistance. Trop Dis Travel Med Vaccines. 2015;2:10. - PMC - PubMed
    1. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5. 10.1038/nature12876 - DOI - PMC - PubMed
    1. World Health Organisation Global Malaria Programme. Status report on artemisinin resistance and artemisinin-based combination therapy efficacy. Geneva: The Organisation; 2018 Aug [cited 10 May 2020]. https://apps.who.int/iris/bitstream/handle/10665/274362/WHO-CDS-GMP-2018...
    1. Amato R, Miotto O, Woodrow CJ, Almagro-Garcia J, Sinha I, Campino S, et al. Genomic epidemiology of artemisinin resistant malaria. Elife. 2016;5:e08714. - PMC - PubMed

Publication types

LinkOut - more resources